Bone Marrow Transplantation
Methodology & AI Transparency ⓘ
Bone Marrow Transplantation Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones.
- 2 Real-world patient consensus: Clinical coding for Bone Marrow Transplantation uses ICD-10 C91.0 across Cancer & Oncology specialty care.
- 3 Typical cash cost range: Differential triage of Bone Marrow Transplantation (C91.0) utilizes radiation) paired with in Bone Marrow Transplantation (C91.0: proactive supportive symptom).
- 4 Top reported side effects / signs: Objective lab/clinical target for Bone Marrow Transplantation: Comprehensive Metabolic & in Bone Marrow Transplantation (C91.0: Organ Function Panel) (Preserved renal/hepatic clearance (C91.0)) and Pathology / Molecular in Bone Marrow Transplantation (C91.0: Genomic Staging).
Ask our AI Specialists anything about Bone Marrow Transplantation
What Is Bone Marrow Transplantation?
Bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into red blood cells, which carry oxygen throughout the body, white blood cells, which fight infections, and platelets, which help the blood to clot. A bone marrow transplant is a procedure that replaces a person's faulty bone marrow stem cells.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Bone Marrow Transplantation (ICD-10 C91.0) is driven by potential lymphatic or in Bone Marrow Transplantation (C91.0: hematogenous dissemination if); Cross-referenced with NIH MeSH (Bone Marrow Transplantation), specialists in Cancer, Oncology & Supportive Care monitor Pathology / Molecular in Bone Marrow Transplantation (C91.0: Genomic Staging) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Severe blood diseases such as thalassemias , aplastic anemia , and sickle cell anemia
- • Certain immune deficiency diseases
- • Presentation of Bone Marrow Transplantation (C91.0): unexplained bleeding, chronic in Bone Marrow Transplantation (C91.0: hoarseness/cough, or progressive)
- • Secondary Bone Marrow Transplantation clinical sign: abnormality detected early in Bone Marrow Transplantation (C91.0: on age-appropriate screening)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Bone Marrow Transplantation Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | C91.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Cancer, Oncology & Supportive Care | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Comprehensive Metabolic & in Bone Marrow Transplantation (C91.0: Organ Function Panel) | Preserved renal/hepatic clearance (C91.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Pathology / Molecular in Bone Marrow Transplantation (C91.0: Genomic Staging) | Guideline-concordant surveillance (C91.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Complete Blood Count in Bone Marrow Transplantation (C91.0: (ANC, Hemoglobin, Platelets)) | Safe hematologic reserve (C91.0) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Bone Marrow Transplantation
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Busulfan Myleran • RxCUI 253113 | Alkylating Drug | 83% | $0.3900 | $ 24.30 /mo |
| Thiotepa Tepadina • RxCUI 1660004 | Alkylating Drug | 78% | $0.3600 | $ 23.08 /mo |
| Treosulfan Grafapex • RxCUI 2703570 | FDA Prescription Therapeutic Agent | 78% | $0.2500 | $ 18.63 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Bone Marrow Transplantation)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Testosterone supplementation and bone: What a 3,103-Participant Study Found TRT is able to inhibit bone resorption and increase bone mass, particularly at the lumbar spine level and when the duration is long enough to allow the anabolic effect of T and estrogens on bone metabolism to take place. Journal of endocrinological investigation • 2022-05-15 • Meta-Analysis | N = 3,103 | 99/100 | PMID 35041193 ↗ |
| New Insights on Different Anti-Hyperglycaemic Treatments on Bone Turnover Markers and Bone: What a 4,914-Participant Study Found High heterogeneity and diverse follow-up durations among studies were evident, which obscures the validity of the results. International journal of molecular sciences • 2024-07-22 • Meta-Analysis | N = 4,914 | 99/100 | PMID 39063229 ↗ |
| New Insights on Contrasting Bone Profiles in PCOS Are Related to: What a 1,822-Participant Study Found The findings of this study alert for a low bone mass, low bone formation, and increased bone resorption PCOS with a BMI <27 kg/m2. The Journal of clinical endocrinology and metabolism • 2024-09-16 • Meta-Analysis | N = 1,822 | 94/100 | PMID 38739756 ↗ |
| New Insights on Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A: What a 447-Participant Study Found We did not find sufficient evidence to suggest any detrimental effect of pelvic XRT on the treatment effect from denosumab on percent BMD change, with only an approximately 5% incidence of clinical fractures. International journal of radiation oncology, biology, physics • 2024-05-01 • Phase III Randomized Trial | N = 447 | 93/100 | PMID 37924987 ↗ |
| New Insights on Benefits and safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients: What a 357-Participant Study Found Denosumab biosimilar QL1206 had promising efficacy, tolerable safety, and how the body absorbs the medicine equivalent to denosumab and could benefit patients with bone metastases from solid tumors. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy • 2023-03-15 • Phase III Randomized Trial | N = 357 | 93/100 | PMID 36802320 ↗ |
Bone Marrow Transplantation Patient Community & “People Like Me” Threads
Filter Bone Marrow Transplantation community threads and patient logs by age, biological sex, dosage, and treatment duration.